Litigation Details for Alvotech USA Inc. v. Abbvie Inc (E.D. Va. 2021)
✉ Email this page to a colleague
Alvotech USA Inc. v. Abbvie Inc (E.D. Va. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-05-11 |
| Court | District Court, E.D. Virginia | Date Terminated | 2021-10-22 |
| Cause | 35:1 Patent Non-Infringement - Declaratory Judgment | Assigned To | Raymond Alvin Jackson |
| Jury Demand | Plaintiff | Referred To | Douglas E. Miller |
| Patents | 8,420,081; 8,889,136; 8,926,975; 8,961,973; 9,067,992; 9,085,619; 9,090,689 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Alvotech USA Inc. v. Abbvie Inc
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Alvotech USA Inc. v. Abbvie Inc (E.D. Va. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-05-11 | 1 | Complaint | THE PATENTS-IN-SUIT U.S. Patent No. 8,420,081 78.…78. U.S. Patent No. 8,420,081 (“the ’081 patent”), titled “Antibody Formulations and Methods of Making…the way for market entry of AVT02: U.S. Patent Nos. 8,420,081; 9,085,619; 8,926,975; and 8,961,973. …Declaratory Judgment of Non-infringement of U.S. Patent No. 8,420,081) 82. Plaintiffs re-allege the…Declaratory Judgment of Invalidity of U.S. Patent No. 8,420,081) 87. Plaintiffs re-allege | External link to document |
| 2021-06-02 | 33 | Memorandum in Support | N.D. Ill.); Ex. 16. Two of those patents, U.S. Patent Nos. 8,420,081 and 9,085,619 are directed to novel… OTHER AUTHORITIES U.S. Patent Nos. 8,420,081 ........................................… statutorily required “patent dance”; and applied for patents at the Patent Office. None of these theories…AbbVie’s other patents, the patents-in-suit have been battle tested. For example, the Patent Office has …validity of the ’619 patent, and another challenging a patent related to the ’973 patent. Ex. 5. | External link to document |
| 2021-10-22 | 51 | Order on Motion to Dismiss | litigation under the BPCIA: U.S. Patent Nos. 8,420,081; 9,085,619; 8,926,975; and 8,961,973. Compl. at 4; Defs…at 7. During the patent dance, Plaintiffs identified four out of 62 potential patents for litigation…Alvotech hf. infringed on the four patents identified during the patent dance. Plaintiffs then tiled the…infringement of the remaining 58 patents identified during the patent dance. In June 2021, …Ranganathan Decl. 12. ABL manufactures and owns the patents for adalimumab, the active ingredient in HUMIRA | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
